4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-030037
CEO and CFO bought 1,000 shares at $9.97 ($9,970)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-08-22 | Purchase | +1,000 | $9.97 | $9,970 | 5,291,177 | D |
| Open-market purchases · 1,000 sh · avg $9.97 · $9,970 | |||||||
Loading xslF345X05/ownership.xml…